Supplementary Table from Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors

Diwakar Davar,Roberta Zappasodi,Hong Wang,Girish S. Naik,Takami Sato,Todd Bauer,David Bajor,Olivier Rixe,Walter Newman,Jingjing Qi,Aliya Holland,Phillip Wong,Lianna Sifferlen, Diane Piper,Cynthia A. Sirard,Taha Merghoub,Jedd D. Wolchok,Jason J. Luke

crossref（2023）

引用 0|浏览51

暂无评分

摘要

Supplementary Table from Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要